Measurement and Mathematical Characterization of Cell-Level Pharmacokinetics of Antibody-Drug Conjugates: A Case Study with Trastuzumab-vc-MMAE.

about

Measurement and Mathematical Characterization of Cell-Level Pharmacokinetics of Antibody-Drug Conjugates: A Case Study with Trastuzumab-vc-MMAE.

Item

http://www.wikidata.org/entity/Q38618106

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Measurement and Mathematical C ...... tudy with Trastuzumab-vc-MMAE.

@en

type

Item

label

Measurement and Mathematical C ...... tudy with Trastuzumab-vc-MMAE.

@en

prefLabel

Measurement and Mathematical C ...... tudy with Trastuzumab-vc-MMAE.

@en

P1476

Measurement and Mathematical C ...... tudy with Trastuzumab-vc-MMAE.

@en

P2093

Aman P Singh

http://www.w3.org/2001/XMLSchema#string

Dhaval K Shah

http://www.w3.org/2001/XMLSchema#string

P2860

Sobol Sensitivity Analysis: A Tool to Guide the Development and Evaluation of Systems Pharmacology Models

A priori prediction of tumor payload concentrations: preclinical case study with an auristatin-based anti-5T4 antibody-drug conjugate

Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugate.

A methodology for performing global uncertainty and sensitivity analysis in systems biology.

Correlation between HER-2/neu(erbB-2) expression level and therapeutic effect of combination treatment with HERCEPTIN and chemotherapeutic agents in gastric cancer cell lines.

Evolution of Antibody-Drug Conjugate Tumor Disposition Model to Predict Preclinical Tumor Pharmacokinetics of Trastuzumab-Emtansine (T-DM1).

Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design.

Pharmacokinetic considerations for antibody drug conjugates.

Antibody-drug conjugates: an emerging concept in cancer therapy.

Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate Development.

P31

scholarly article

P356

10.1124/DMD.117.076414

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28821484

http://www.w3.org/2001/XMLSchema#string

P932

5625284

http://www.w3.org/2001/XMLSchema#string